Patent 9884075 was granted and assigned to California Institute of Technology on February, 2018 by the United States Patent and Trademark Office.
Disclosed herein are genetically engineered T cell receptors, and methods, vectors, and genetically engineered T cells related to genetically engineered T cell receptors.